Seaport Therapeutics, Inc. (SPTX) return on equity (ROE)

There is no return on equity history on record here for Seaport Therapeutics, Inc. (SPTX). Figures as of 17 Nov 2026, 21:25 UTC, from Yahoo Finance.

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of return on equity needs at least 3 fiscal years; none is on record here for Seaport Therapeutics, Inc.. Nothing is estimated to fill the gap.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on SPTX

Seaport Therapeutics, Inc., figure by figure

Seaport Therapeutics, Inc. (SPTX) overview: price, valuation and scorecard

Seaport Therapeutics, Inc. return on equity (ROE): questions and answers

How is Seaport Therapeutics, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Seaport Therapeutics, Inc. (SPTX) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/SPTX/roe

Underlying data: Yahoo Finance.